BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24120862)

  • 1. Bisphosphonates target B cells to enhance humoral immune responses.
    Tonti E; Jiménez de Oya N; Galliverti G; Moseman EA; Di Lucia P; Amabile A; Sammicheli S; De Giovanni M; Sironi L; Chevrier N; Sitia G; Gennari L; Guidotti LG; von Andrian UH; Iannacone M
    Cell Rep; 2013 Oct; 5(2):323-30. PubMed ID: 24120862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant.
    Bielinska AU; Makidon PE; Janczak KW; Blanco LP; Swanson B; Smith DM; Pham T; Szabo Z; Kukowska-Latallo JF; Baker JR
    J Immunol; 2014 Mar; 192(6):2722-33. PubMed ID: 24532579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPRC6A mediates Alum-induced Nlrp3 inflammasome activation but limits Th2 type antibody responses.
    Quandt D; Rothe K; Baerwald C; Rossol M
    Sci Rep; 2015 Nov; 5():16719. PubMed ID: 26602597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
    Seydoux E; Liang H; Dubois Cauwelaert N; Archer M; Rintala ND; Kramer R; Carter D; Fox CB; Orr MT
    J Immunol; 2018 Jul; 201(1):98-112. PubMed ID: 29769270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.
    Gavin AL; Hoebe K; Duong B; Ota T; Martin C; Beutler B; Nemazee D
    Science; 2006 Dec; 314(5807):1936-8. PubMed ID: 17185603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses.
    Boscardin SB; Hafalla JC; Masilamani RF; Kamphorst AO; Zebroski HA; Rai U; Morrot A; Zavala F; Steinman RM; Nussenzweig RS; Nussenzweig MC
    J Exp Med; 2006 Mar; 203(3):599-606. PubMed ID: 16505139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Lipopolysaccharide from Pantoea Agglomerans Is a Promising Adjuvant for Sublingual Vaccines to Induce Systemic and Mucosal Immune Responses in Mice via TLR4 Pathway.
    Fukasaka M; Asari D; Kiyotoh E; Okazaki A; Gomi Y; Tanimoto T; Takeuchi O; Akira S; Hori M
    PLoS One; 2015; 10(5):e0126849. PubMed ID: 25978818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isatis indigotica root polysaccharides as adjuvants for an inactivated rabies virus vaccine.
    Zhang W; Zheng X; Cheng N; Gai W; Xue X; Wang Y; Gao Y; Shan J; Yang S; Xia X
    Int J Biol Macromol; 2016 Jun; 87():7-15. PubMed ID: 26875535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses.
    Phipps JP; Haas KM
    J Infect Dis; 2019 Jan; 219(2):323-334. PubMed ID: 30289460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Di-(2-ethylhexyl) phthalate adjuvantly induces imbalanced humoral immunity in ovalbumin-sensitized BALB/c mice ascribing to T follicular helper cells hyperfunction.
    Han Y; Wang X; Chen G; Xu G; Liu X; Zhu W; Hu P; Zhang Y; Zhu C; Miao J
    Toxicology; 2014 Oct; 324():88-97. PubMed ID: 25093321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses.
    Xiao L; Kim J; Lim M; Dai B; Yang L; Reed SG; Baltimore D; Wang P
    Vaccine; 2012 Mar; 30(15):2570-81. PubMed ID: 22314134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells.
    Dienz O; Eaton SM; Bond JP; Neveu W; Moquin D; Noubade R; Briso EM; Charland C; Leonard WJ; Ciliberto G; Teuscher C; Haynes L; Rincon M
    J Exp Med; 2009 Jan; 206(1):69-78. PubMed ID: 19139170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses.
    Milicic A; Kaur R; Reyes-Sandoval A; Tang CK; Honeycutt J; Perrie Y; Hill AV
    PLoS One; 2012; 7(3):e34255. PubMed ID: 22470545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ocular conjunctiva as a mucosal immunization route: a profile of the immune response to the model antigen tetanus toxoid.
    Barisani-Asenbauer T; Inic-Kanada A; Belij S; Marinkovic E; Stojicevic I; Montanaro J; Stein E; Bintner N; Stojanovic M
    PLoS One; 2013; 8(4):e60682. PubMed ID: 23637758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of immune system function is accelerated in immunocompromised mice by the B-cell-tropic isoxazole R-11.
    Zimecki M; Artym J; Kocięba M; Obmińska-Mrukowicz B; Mączyński M; Ryng S
    Pharmacol Rep; 2012; 64(2):403-11. PubMed ID: 22661192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of IL-1 receptor-associated kinase-M (IRAK-M) in priming of immune and inflammatory responses by nitrogen bisphosphonates.
    Norton JT; Hayashi T; Crain B; Corr M; Carson DA
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11163-8. PubMed ID: 21690387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New TLR7 agonists with improved humoral and cellular immune responses.
    Upchurch KC; Boquín JR; Yin W; Xue Y; Joo H; Kane RR; Oh S
    Immunol Lett; 2015 Nov; 168(1):89-97. PubMed ID: 26381186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.
    Keijzer C; Haijema BJ; Meijerhof T; Voorn P; de Haan A; Leenhouts K; van Roosmalen ML; van Eden W; Broere F
    Vaccine; 2014 May; 32(24):2904-10. PubMed ID: 24598720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.